VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced European commercial availability of the preloaded enVista Envy ful…
Category: News
Treating IgG4-RD: How Far Will B-Cell Drugs Take the Field?
Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics. Medscape Medical News
Docs, Lawsuit Challenge Medicare WISeR Prior Auth Experiment
Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security. Medscape Medical News
Sarcoid Uveitis: 1 in 3 Achieve Remission, Relapses Rare
Remission is achievable and relapses are uncommon in patients with sarcoid uveitis, although those with swelling in the macular region may experience delayed remission. Medscape Medical News
GLP-1 Drugs Under Scrutiny: How Real Are the Risks?
Gastrointestinal adverse effects remain a key barrier to continued use of these agents, with slower dose titration emerging as a strategy to improve tolerability and adherence. Medscape News Europe
Myopia Numbers Are Rising. Our Response Should Be Too
With myopia affecting 1 in 3 people, eye experts are urging clinicians to act now to slow progression in patients. Medscape Medical News
Female Eye Doctors Earn Less Across All Ranks
Women in academic ophthalmology earn less than men across all ranks, with a pay-gap over a full career of roughly $1 million, a study finds. Medscape Medical News
Myth of the Month: GLP-1s Have Many Dangerous Side Effects
Dr Paauw debunks concerns about thyroid cancer, suicide, and pancreatitis. Medscape Internal Medicine
Alcon Publishes Agenda for 2026 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon Publishes Agenda for 2026 Annual General Meeting
Alcon Publishes Agenda for 2026 Annual General Meeting
GENEVA–(BUSINESS WIRE)–Alcon Publishes Agenda for 2026 Annual General Meeting
Vascular Complications Tied to Poor CRC Outcomes in Diabetes
In patients with colorectal cancer undergoing major resection surgery, a greater severity of diabetes-related vascular complications is linked to poorer postoperative outcomes, including mortality. Medscape News UK
Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of a pivotal Phase 2b/3 trial evaluating MK-8748 (also known as Tiespectus, EYE201), a novel investigational bispecif…
Immunovant’s Treatment for Eye Disease Fails in Late-stage Trials
Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in patients with moderate-to-severe thyroid eye disease in two late-stage… Reuters Health Information
Ray Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RTx-015 in Retinitis Pigmentosa
BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics (RayTx), a clinical-stage biopharmaceutical company pioneering optogenetic therapies for those living with retinal degenerative diseases, today announced that the U.S. Food and Drug Administration (FD…
Amprion Grows Global Footprint with Australian Partnership & Expanded Research Collaborations
SAN FRANCISCO–(BUSINESS WIRE)–Amprion Grows Global Footprint with Australian Partnership & Expanded Research Collaborations
Amaros Launches Interventional Glaucoma Network to Advance Evidence in Interventional Glaucoma
ATHERTON, Calif.–(BUSINESS WIRE)–Amaros Launches Interventional Glaucoma Network to Advance Evidence in Interventional Glaucoma
Amaros Launches Interventional Glaucoma Network to Advance Evidence in Interventional Glaucoma
ATHERTON, Calif.–(BUSINESS WIRE)–Amaros Launches Interventional Glaucoma Network to Advance Evidence in Interventional Glaucoma
The Death of the Medical Fax Is Foretold — Again
Medical offices are sick and tired of faxing, and federal officials agree. But modernization won’t be easy. Medscape Medical News
Viridian Eye Disease Drug Disappoints on Efficacy Despite Trial Success
Viridian Therapeutics’ experimental treatment for thyroid eye disease lagged rivals in efficacy in a late-stage… Reuters Health Information
Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026
BENGALURU, India–(BUSINESS WIRE)–Biocon Limited (BSE: 532523; NSE: BIOCON) today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1, 2026, following approvals from the Nomination &…